McDermottPlus advises medical device and diagnostics manufacturers and laboratories of all sizes, from startups to multinational corporations. We serve some of the United States’ most innovative advanced diagnostics laboratories and diagnostic kit developers.
On behalf of a diagnostic test manufacturer, developed and deployed an advocacy strategy that persuaded the Centers for Medicare and Medicaid Services (CMS) to reverse its proposal to reduce payment for a test by 75 percent, and convinced CMS to allow local Medicare contractors to continue to locally price claims
On behalf of a coalition of diagnostic testing suppliers, successfully advocated for changes in a critical practice expense input under the Medicare Physician Fee Schedule
On behalf of a coalition of laboratory test manufacturers, successfully advocated for changes to a section of CPT® codes and the subsequent valuation of those codes under the Medicare Physician Fee Schedule to improve payment rates
On behalf of a manufacturer of diagnostic imaging agents and products, persuaded CMS to reverse a proposal that would have reduced reimbursement for echocardiogram procedures using contrast agents because of reconfiguration of the relevant APCs under the OPPS